Treatement lines and herceptin for HER2+ metastatic breast cancer

Any patient with metastatic breast cancer (MBC) will be familiar with the concept of ‘treatment lines’. Unlike primary breast cancer, where you undergo chemotherapy for a fixed time period, after

Herceptin report re access to 3rd and subsequent line of therapy problem with drug access

10th July 2020 Hi Debbie, Trying to condense the points from the June email with attachments I sent you. Going forward what we would like now is – for you